Tumour GDF-15 Expression and Clinical Outcomes in Intermediate-Risk Metastatic Clear-Cell Renal Cell Carcinoma Treated with Second-Line Nivolumab.

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://www.ncbi.nlm.nih.gov/pubmed/42782878

Ahmet Ozet; Betul Ogut; Burcu Ulas Kahya; Hatice Azra Begum Salimoglu; Ipek Isik Gonul; Melike Urganci; Nuriye Ozdemir; Orhun Akdogan; Osman Sutcuoglu; Ozan Yazici; Tuba Ugur Tuzcu

Sep 25, 2026